Shenzhen Neptunus Bioengineering ST海王

Pharmaceutical Distribution 医药商业

¥1.50−¥0.05 · −3.23%Delayed 行情延迟 · 28 Sep 2026 · 16:14 CST · CNY

Open 开盘

¥1.54

High 最高

¥1.55

Low 最低

¥1.49

Prev Close 昨收

¥1.55

Volume 成交量

5,081.6万股

Turnover 成交额

¥7,667.1万

Mkt Cap 总市值

¥39亿

P/E 市盈率

−4.9×

Recent Activity 近期动态All Filings 全部公告 →

13 significant filings since 1 Jun 2026: 1 on share pledge, 1 on litigation and 1 on regulatory action, and 3 other kinds. The latest, on 28 Sep 2026: 关于转让控股子公司股权被动形成对外财务资助的公告. On 15 Jul 2026 the company said it expects net profit for the period ending 30 Jun 2026 to fall by 510.33% to 668.15% from the same period a year earlier.
自 1 Jun 2026 起有 13 份重大公告：share pledge 1 份、litigation 1 份、regulatory action 1 份，另有 3 类。最新一份（28 Sep 2026）：关于转让控股子公司股权被动形成对外财务资助的公告。15 Jul 2026 公司预告截至 30 Jun 2026 的净利润较上年同期下降 510.33% 至 668.15%。

Price History 价格走势

250 trading days 个交易日 · High 最高 ¥5.29 · Low 最低 ¥1.29

1D 5D 1M 3M 6M YTD 1Y 5Y MAX

Line 折线 Area 面积 Candles K线 Bars 美国线

2.003.004.005.00

Volume 成交量

7.64亿

Sep 25Dec 25Mar 26Jul 26Sep 26

Overview 概览 Deep Report 深度报告 Financials 财务 Valuation 估值 Ownership 股东 Analysts 券商 Estimates 预测 News 动态 Events 事件 Peers 同业

Last Twelve Months 近十二个月

No broker reports from the last twelve months are held for this company. Brokers covered 1,059 of the 2,940 SZSE listings (36%) over the same period. 近十二个月无本公司研报；同期券商覆盖了 2,940 只 SZSE 证券中的 1,059 只（36%）。

Rating Changes 评级变动

No broker has changed its rating on this company in the reports held.